Technology acceptance and actual use of the Medical-Dashboard eHealth application in kidney transplants recipients by Zonderop, Vera
1 
 
 
The Medical Dashboard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis Health Psychology 
Faculty of Social Sciences – University of Leiden 
June 2016 
Student number: s1029762 
Supervisor: dr. S. van Dijk 
Unit: Health, Medical and Neuropsychology 
Technology acceptance and actual use of the 
Medical-Dashboard eHealth application in 
kidney transplant recipients  
 
 
Vera Zonderop 
 
 
 
 
 
 
 
2 
 
 
The Medical Dashboard 
 
Abstract 
Background The integration of a new eHealth self-monitoring application (e.g., monitoring 
blood pressure, weight, temperature and steps), can help kidney transplant recipients and 
health care providers tracking important health information the first year after transplantation. 
However, whether patients with chronic kidney disease actually use internet-delivered 
interventions is still an underexplored area of research.                                                        
Purpose This study examines the influence of self-efficacy, transplant worries, ease of use 
and usefulness on the actual usage of the Medical Dashboard (MD) eHealth technology. 
Additionally, the effect of self-efficacy on perceived ease of use and transplant worries on 
perceived usefulness will be assessed.                                                                                 
Method A prospective questionnaire study was conducted at the Leiden University Medical 
Centre (LUMC) with a sample of 23 transplant recipients. The Technology Acceptance Model 
(TAM) was used to explain the possible predictors of usage. Furthermore two additional 
factors, self-efficacy and transplant worries were added to the model.              
Results Higher levels of self-efficacy, transplant worries, perceived ease of use and perceived 
usefulness did not result in higher levels of actual usage. Additionally, self-efficacy was not 
associated with the perceived ease of use of the MD. Patients with higher levels of transplant 
worries did perceive the MD as more useful than less worrisome patients.                 
Conclusions The current version of the TAM is not yet able to predict actual usage of the MD 
eHealth technology. Future eHealth studies should improve the predictive ability of the TAM 
by sufficiently tailoring the model to the health-care setting. For instance, incorporate social 
and organizational factors such as professional support or personal feedback. Second, self-
efficacy regarding self-management had no effect on perceived ease of use. Finally, recipients 
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experiencing higher levels of transplant related worries might benefit most from the MD 
eHealth application.   
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BACKGROUND 
 
Kidney function & End Stage Renal Disease 
The role of kidneys is very broad and has various effects on the human body. For instance, it 
includes excretion and filtration of the nitrogenous wastes generated by the body each day, 
and it regulates the conservation of homeostasis in the form of fluid /electrolyte balance 
(Boyer & Paharia, 2008; Junqueira & J. Carneiro, 2007; Nierstichting, 2015; The National 
Institute of Diabetes and Digestive and Kidney Diseases, 2015). Moreover, the kidneys 
release hormones to regulate blood pressure and stimulate bone marrow to produce red blood 
cells (Amir & Winchester as cited in Boyer and Paharia, 2008; Junqueira & J. Carneiro, 2007; 
NIDDK, 2015; Nierstichting, 2015). However, when the kidneys do not function in a normal 
way, we can speak of chronic kidney disease (Boyer & Paharia, 2008). Chronic kidney 
disease (CKD) can progress to the most severe form: End-stage Renal Disease (ESRD).  
Treatment is then needed to replace renal function, because of irreversible atrophy of the 
kidneys (Haynes & Winearls, 2010; Roderick, 2002).    
Unfortunately, the burden of kidney disease is growing. The NIDDK (2015) states that 
in the US one in ten American adults, more than 20 million people, have a level of CKD. 
Besides the high prevalence of CKD and ESRD highly prevalent, the diseased are also  
expensive to treat. In 2009 the expenses on ESRD patients in the United States were more 
than $40 billion (NIDDK, 2015). A major reason for the high costs related to CKD and ESRD 
is the expensive renal replacement therapy (RTT), a treatment which includes dialysis and 
transplantation. 
Treatment 
RTT mostly involves dialysis for treating ESRD of which the most common forms are 
hemodialysis (HD) and peritoneal dialysis (PD). HD comprises complex processes; it 
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involves an dialyzer wherein the patient’s blood is exchanged through a semipermeable 
membrane. A connection is made between the dialyzer and the body of the patient 
arteriovenous (connection between a vein and an artery) or through a catheter (Boyer & 
Paharia, 2008). According to the NIDDK (2015), patients can also choose for home HD 
besides in-center HD. Home HD involves a smaller machine that is easier to use and has 
many benefits. PD involves a surgical placement of an intra-abdominal catheter and 
exchanges can also take place at home, four or five times a day or at night. Some patients 
decide to use PD because it is less intrusive on their lives than HD, besides, when PD is 
conducted at home, patients state to feel more free (Boyer & Paharia, 2008).  
Another form of RTT involves renal transplantation. Compared to the different forms 
of dialysis, transplantation is more cost-effective, provides a higher state of well-being and 
increases the long-term survival (Davis & Delmonico, 2005). However, there are downsides 
to this type of treatment, because renal transplantation is an invasive surgical procedure and 
not always successful. Patients must be healthy enough to endure the operation and have to 
deal with the difficulties of long-term immunosuppressive medications and the risk of life-
long kidney rejection (Boyer & Paharia, 2008). Moreover, RTT can have various effects on 
Health-related Quality of Life (HRQoL) of renal recipients.                                                                            
Health-related Quality of Life and Anxiety  
HRQoL is an important measure to consider in kidney patients because it reflects the 
wellbeing of an individual and the capability to function in daily life (Avramovic & 
Stefanovic, 2011). The World Health Organization (1948) defines HRQoL as a 
multidimensional and comprehensive measurement that is connected to the individual’s 
health. However, a mixed positive and negative impact on Health-related Quality of Life 
(HRQoL) in kidney patients was found in previous literature. Several reviews (Avramovic & 
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Stefanovic, 2012; Liem, Bosch & Hunink, 2008) showed that the overall HRQoL is higher in 
renal transplant patients compared to dialysis patients. For instance, lower levels of distress 
and a higher psychological well-being was noted in transplant patients. Likewise, Griva and 
colleagues (2002) concluded that renal transplantation is attractive and helpful in largely 
restoring the HRQoL of ESRD-patients.        
 On the other hand, research suggests that a majority of patients worry about the 
viability of the transplant and the emotional responses to the transplantation. A reasonable 
number of studies (Látos et al., 2012; Pascazio et al., 2010; Pisanti et al., 2014) point toward 
the prevalence of significant negative emotions and transplant worries about allograft (organ 
tissue) dysfunction, in renal transplant recipients. These worries might negatively affect 
HRQoL (Griva et al., 2002).  To keep functioning in daily life with all the various difficulties 
and demands of having ESRD, self-management is vital.  
 
Self-management             
Self-management demands for kidney patients are extensive. A prior review (Barlow, Wright, 
Sheasby, Turner & Hainsworth, 2002) defines self-management as: ‘The individual’s ability 
to manage the symptoms, treatment, physical and psychological consequences and life style 
changes inherent in living with a chronic condition’. Self-management is mandatory and 
requires extensive lifestyle restrictions of the kidney patient, such as strict dietary behavior, 
control over fluid and potassium intake, blood pressure and medication management (Ong, 
Jassal, Porter, Logan & Miller, 2013). In addition, managing one’s disease includes 
(self)monitoring for rejection and infection in the first year after transplantation, and is of 
great importance (Boyer & Paharia, 2008). Examples are (self)monitoring of blood pressure, 
weight and temperature. Self-care behaviour (a dimension of self-management) can have a 
direct and positive influence of self on the quality of life in kidney transplant recipients 
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(Weng, Dai, Huang & Chiang, 2010).        
 Moreover, Self-management can be enhanced by health care workers in various ways, 
by teaching the patient problem-solving skills for instance. Accordingly, patients might learn  
how to take healthier decisions and actions (Bodenheimer, Lorig, Holman & Grumbach, 
2002). Finally, the concept of self-management also includes active patient participation 
(Novak, Costantini, Schneider & Beanlands, 2013), which in turn is an essential feature of 
shared decision making (SDM) between patient and provider (Lorig & Holman, 2003).  
Active patient participation and shared decision making 
Patients who are actively engaged in their own care, experience better health outcomes,  
improvements in blood pressure, cholesterol levels and self-rated health status (Simmons, 
Wolever, Bechard & Snyderman, 2014). In their review, Simmons and colleagues (2014) 
defined patient engagement as: (1) understanding the importance of taking an active role in 
one’s health; (2) having knowledge, skills, and confidence to manage health and chronic 
conditions; and (3) performing health-promoting behaviors.     
 Moreover, active patient engagement is important in making shared decisions and 
SDM can be seen as an element of patient-centered care (Brand & Stiggelbout, 2013). Elwyn 
and colleagues (2010) defined SDM as: ‘An approach where clinicians and patients make 
decisions together using the best available evidence, where patients are encouraged to think 
and communicate about their preferences for selecting the best course of action’.  
  Currently, hospitals and other health care instances are trying to create opportunities to 
keep up with these new emerging trends by using for instance eHealth applications. Kamel 
and Wheeler state (as cited in Neuhauser & Kreps, 2010) there is a rapid rise of eHealth 
communication activities through computers and mobile phones. For instance in a web-based 
portal, which can empower patients to participate and communicate with their care providers 
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and to self-monitor symptoms in online diaries (Van der Vaart, Drossaert, De Heus, Taal & 
Van de Laar, 2013). 
eHealth 
eHealth involves several overlapping areas such as telemedicine, telehealth, and medical 
informatics (Neuhauser and Kreps, 2003) and strategies in eHealth include health information 
on the internet, support groups, computer-assisted learning, health interventions and apps. 
These new and innovative technologies provide opportunities to contribute to health care and 
make profounder contacts with clients and supporters, including clinicians and patients. 
(Neuhauser & Kreps, 2003). Diamantidis and Becker (2014) suggest that the integration of 
new health information technology (IT) platforms into the existing structures of health care 
for CKD can be an addition to the current strategies for improving health outcomes. For 
instance the integration of a new eHealth self-monitoring application (e.g., blood pressure), 
which enables transplant recipients and health care providers to track important health 
information (Smarr et al., 2011). Even though the number of eHealth interventions is 
increasing,  in their review Kohl, Crutzen & de Vries (2013) stated that the use of internet-
delivered interventions is still an underexplored area of research. For this reason it is 
important to evaluate new eHealth interventions and to question ourselves to which extend 
patients are able to cope with and accept new eHealth interventions. 
Technology Acceptance Model 
A method often used for evaluating the acceptance or rejection towards a new technology is 
the Technology Acceptance Model (TAM). This model (one example illustrated in Figure 1) 
is a widely used, reliable and predictive model that explains the possible behavioral intention 
to use a technical innovation (Davis, as cited in King & He, 2006). This behavioral intention 
is assumed to be predicted by two main convictions: perceived usefulness and perceived ease 
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of use of a technology (Davis, as cited in Sharp, 2007). Traditionally, the model suggests that 
a person is more likely to use an application when he or she believes it to be useful (Morris & 
Dillon, 1997).  
 
Figure 1. TAM and four categories of modifications. Reprinted from ‘A meta-analysis of the 
technology acceptance model,’ by W. R. King, and J. He, 2006, Information & Management 
43, p. 740–755 Copyright 2006 by Elsevier 
TAM has shown to be a trustworthy predictive model, with a lot of modifications been made 
during the past years. However, there remain some questions regarding the predictive value of 
the TAM (Marangunić & Granić, 2015). First, previous investigations of the TAM 
predominately used student participants and it is advised to investigate the TAM in real 
organizational/business environments (Legris, Ingham & Collerette, 2003). Second, a better 
understanding is needed of predictive factors that contribute to possible outcome variables of 
the TAM. This could enhance our understanding of the acceptance of new information 
technologies (Amoako-Gyampah & Salam, 2004; Karahanna & Straub, 1999; Marangunić & 
Granić 2015; Moon & Kim, 2001). A final limitation is that most studies use self-report 
questionnaires to measure whether the application is actually used, instead of relying on 
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objective statistical measures of actual system use (Donkin et al. 2011; Legris, Ingham & 
Collerette, 2003). 
Actual usage 
Self-reports on the outcome of actual usage have several limitations, for example previous 
studies observed a weak link between self-reported usage and actual usage (Straub et al., 
1995). Therefore, measuring objective actual use is ideal (Devaraj & Kohli, 2003; Venkatesh, 
Brown, Maruping & Bala, 2008), especially when the goal of research is to describe the 
determinants of use. Actual usage is an objective measure of system usage defined by Straub 
et al. (1995) as: ‘computer-recorded system usage, categorized as heavy, moderate, light or 
nonuse based on distribution of actual usage’. Actual usage is an important factor to integrate 
in the TAM, for instance the review of Donkin and colleagues (2011) pointed out that 
program use of e-therapy is positively associated with physical health outcomes of 
interventions. For instance, weight management outcomes and interventions aiming at 
nutrition and vegeTable intake health outcomes (Donkin et al., 2011).   
Self-efficacy 
Additionally, self-efficacy might be an important predictive factor in the acceptance of new 
technologies, because self-efficacy is found to increase the use of an intervention (Kohl, 
Crutzen & de Vries, 2013) and is not explicitly defined in the TAM. Bandura (1997) describes 
self-efficacy as: ‘The confidence that one can carry out a behaviour necessary to reach a 
desired goal’. Moreover, Barlow, Wright, Sheasby, Turner and Hainsworth (as cited in 
O’Brien et al., 2013) state that self-efficacy has been found to be the largest predictor of a 
person’s capability to adjust risky health behaviours by taking action. In line with the above, it 
is suggested that an increased level of self-efficacy is associated with an increased use of an 
new eHealth technology for monitoring health parameters.     
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Furthermore, self-efficacy is assumed to have a positive effect on the perceived ease of use. 
The reasoning behind this assumption can be found in the Social Cognitive Theory (SCT) of 
Bandura (1977, 1997).  The SCT states that the expectations of an individual’s self-efficacy is 
believed to influence the kind of decisions someone makes. These decisions can determine 
how persisting and endeavouring one is in performing certain behaviour (Bandura, 1977, 
1997). Regarding a new eHealth technology, someone might find a new technology easier to 
use as a consequence of  their level of self-efficacy. 
Transplant worries 
Another predictive factor suggested is transplant worries. As mentioned before, anxiety is 
prevalent in transplant recipients and is associated with worries about transplant dysfunction, 
and fear of kidney rejection (Baines, Jones & Jindal, 2002; Griva et al., 2002; Látos et al., 
2012; Pascazio et al., 2010; Pisanti et al., 2014). In the current study it is suggested that 
patients with high levels of anxiety will use new self-monitoring health technologies more 
often, because self-monitoring showed positive effects on feelings of confidence in taking 
control of own care (Jones et al., 2012) and increased feelings of security and reassurance 
(Jaana, Pare & Sicotte, 2012). Correspondingly, we assume that transplant recipients with 
increased levels of transplant worries will benefit more from a new self-monitoring 
application and therefore will find it more useful, in comparison to less worrisome transplant 
recipients.  
Integrating self-monitoring in health care 
Last of all, only a few self-management applications through web and/or mobile phone are 
momentarily available for chronic kidney patients, in contrary to other chronic illnesses like 
diabetes or cardiovascular diseases (Diamantidis & Becker, 2014). Besides a low availability, 
the importance of self-monitoring is not always recognized in current health care. Patient’s 
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self-reported health measures, preferences or behavior (e.g., weight, dietary intake) are not 
always taken into account by health care professionals in the decisions made, nor included in 
electronic health records (Glasgow, Kaplan, Ockene, Fisher & Emmons, 2012). This is 
unfortunate, as information from the patient’s perspective is valuable information for 
improving health outcomes. In addition, patients self-reported measures into electronic health 
records can enhance relationships between patient and provider, improve health management, 
produce better information and can improve care and human health (Glasgow et al., 2012).  
AIM 
The aim of the present pilot-study is to evaluate the influence of self-efficacy, transplant 
worries, ease of use and usefulness on the actual usage of the ‘Medical Dashboard (MD), a 
new eHealth technology developed at the LUMC.  Furthermore, the effect of self-efficacy on 
ease of use and transplant worries on perceived usefulness will be assessed. The extended 
version of the TAM will be used as a conceptual framework (Figure 2).     
 This study contributes to the existing body of research examining eHealth applications 
in transplant recipients earlier diagnosed with ESRD. The MD gives an integrated summary 
of hospital and patient- reported health measurements, standardized into the routine of health-
care. Patients will self-monitor blood pressure, pulse, steps, weight and temperature. Results 
from self-monitoring and information from the hospital information system will be integrated 
and displayed in the MD. Moreover, the MD can be used for stimulating (shared) decision 
making and for patients to actively participate in their own health-care process. The following 
research questions and hypotheses are formulated.  
Research question (1): Will self-efficacy, transplant worries, perceived ease of use and 
perceived usefulness have a positive influence on actual usage?    
 Hypothesis 1: Patients with higher levels of self-efficacy will actually use the device 
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more than patients with lower levels of self-efficacy.                                                                                      
 Hypothesis 2: Patients with higher levels of transplantation worries will actually use 
the device more than patients with lower levels of worries.                                       
 Hypothesis 3: Patients with higher levels of perceived ease of use will actually use the 
device more than patients with lower levels of ease of use.     
 Hypothesis 4: Patients with higher levels of perceived usefulness will actually use the 
device more than patients with lower levels of perceived usefulness.   
 Research question (2): Does self-efficacy influence the perceived ease of use of the 
Medical Dashboard eHealth intervention?       
 Hypothesis 5: Patients with higher levels of self-efficacy will have a higher perceived 
ease of use than patients with lower levels of self-efficacy.      
Research question (3): Does transplantation related worries influence the perceived 
usefulness of the Medical Dashboard eHealth intervention?  
Hypothesis 6: Patients with higher levels of transplantation worries will perceive the 
device as more useful than patients with lower levels of worries.  
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Figure 2. Proposed conceptual model based on the TAM. 
METHODS 
Design 
   
The Medical Dashboard (MD) was a prospective questionnaire study, conducted at the Leiden 
University Medical Centre (LUMC). The Medical Ethics Committee decided no formal 
procedure was necessary for this study. Data was collected between baseline, mid-October 
2014, and follow-up at April 2015. Self-efficacy, transplant worries, perceived ease of use and 
usefulness data was measured by self-report questionnaires at baseline and at follow-up after 
Actual Usage 
Perceived usefulness 
(U) 
Perceived ease of use 
(EU) 
Self-efficacy 
Transplant worries 
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approximately three months. Blood pressure, pulse, weight, temperature and steps were self-
monitored on the website www.sterkmetvoeding.nl and wearables by the participants.  
Participants 
During the first year after transplantation patients have the highest risk of kidney rejection. As 
a consequence, the first year is the most important period for monitoring physical functions 
regarding kidney rejection. For that reason participation started rapidly after receiving surgery 
at the kidney clinic of the LUMC. Potential participants were identified by the medical 
specialists (nephrologist and nurses) and approached by letter to participate in the pilot-study 
‘the Medical Dashboard’. In total 38 patients were asked to participate and 23 patients 
(response rate = 60.5 %) provided their consent. Most common reasons for not participating 
were: being satisfied with traditional self-monitoring, feeling confronted with possible 
physical weaknesses and the amount of effort. Participation was on a voluntary basis and 
exclusion criteria were (1) insufficient comprehension of the Dutch language, (2) not having 
an email address and (3) not having a computer or laptop. 
Intervention 
Between October 2014 and April 2015 the participants participated in the eHealth 
intervention ‘the Medical Dashboard’. From the start of the intervention, the participants self-
monitored their physical state on a daily base, using the website and apps. The website and 
apps were directly linked to the MD in the Electronic Patient record. Daily updates of self-
monitoring were immediately visible for the doctors at the hospital. The MD gave the 
nephrologists the opportunity to closely monitor the progress of the participant, after surgery. 
Likewise, the participants were able to keep track of  their own progress more closely, and 
could contact the doctor when needed.  
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The MD displayed personal guidelines of particular measurements. The guidelines showed 
personal values for home and hospital-based measurements for the participants to comply to, 
and were visualized with colors. For instance, when a blood pressure measurement met the 
terms of the corresponding guideline, a green color was displayed. When the measurements 
did not met the guidelines, a red color was displayed. Non-compliance of the personal 
guidelines was a reason for discussion between doctor and patient, for instance to slightly 
adjust the guidelines. Moreover, changes in lifestyle, medicine and health goals could be 
made during the consults in the intervention period.  
Procedure                     
Before the start of the intervention, nephrologists of the LUMC were introduced to and 
informed about the study and the MD. They were asked to show and discuss the Medical 
Dashboard with their patients during the consults. Patients who were willing to participate  
engaged in two meetings and were instructed by a Health Psychology student from the 
University of Leiden. During the first (baseline) meeting, participants received information 
about the content of the pilot and received an example of the MD. Furthermore the wearables 
were provided and installed with the required software on their mobile phones. Also 
information about the website www.sterkmetvoeding.nl was given and the participants 
received an instruction manual regarding the website and wearables.   
 Moreover, participants were informed to monitor themselves from the first meeting 
(T0) until a second meeting (T1). Additionally, they were asked to proceed self-monitoring 
their blood pressure, pulse, temperature and weight according to the guidelines of their 
nephrologist. In general this entailed self-monitoring e.g. blood pressure approximately two 
times per day. Self-monitoring steps with the accelerometer was on a voluntary base and was 
recommended to measure on a daily base. At the end of the first meeting a baseline 
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questionnaire was completed by the participant (T0). After the intervention period, 
participants were invited for an evaluation of the MD and completed the follow-up 
questionnaire (T1). All meetings with participants (T0 and T1) took place between October 
2014 until April 2015. The intervention duration (time between T0 and T1) varied across 
participants and ranged from 1 month to 5.5 months (M = 4.27, SD = 1.16). 
Materials 
Four types of measuring instruments were used for self-monitoring during the intervention: 
the Medical Dashboard, a self-care module on the website www.sterkmetvoeding.nl and two 
types of wearables. The MD (as illustrated in appendix 1) gave both patients and doctors 
access to an electronical summary of hospital measurements and home-based self-
measurements. Hospital measurements consisted of creatinine, sodium intake and 24-hours 
urine. Home-based measurements consisted of: blood pressure, pulse, temperature, weight 
and steps. Blood pressure, pulse and steps were tracked by use of two types of wearables that 
were wireless connected to the internet. As a result, self-monitoring data of the participants 
could automatically be uploaded and was directly visible on their mobile phones and the 
website.           
 The following wearables were used (1) ‘the Fitbit’: an accelerometer to record the 
number of steps, and (2) ‘the iHealth’: a wireless blood pressure and pulse measurement 
device. The Fitbit and iHealth app were downloaded in the ‘play store’ or ‘apple store’ for  
mobile phones. The Fitbit wearable was compatible for both computer and smartphone, and 
the iHealth only for smartphone. Therefore, the provision of the wearables depended on 
whether the participants had a computer and/or a smartphone. Participants without a 
compatible smartphone for the Fitbit app were asked to use their computer for installing the 
Fitbit. If a participant did not have a compatible smartphone for the iHealth app, a normal 
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blood pressure instrument was given. Participants could also use their own blood pressure 
device.                 
Moreover, every participant created a personal account on www.sterkmetvoeding.nl, which 
gave access to the self-monitoring results as well as to results of the wearables. Because no 
wireless wearables were used for monitoring weight and temperature, the participants were 
requested to upload their weight and temperature data directly on their personal account on 
the website.  
Measurements 
Actual Usage 
 
The actual usage of the MD e-health application, was indicated by the frequencies of self-
monitoring: blood pressure, pulse and steps, weight and temperature for each participant. This 
was recorded by the wearables and website between baseline and follow-up. For the reason 
that pulse perfectly correlated with the blood pressure records, it was left out of the data-file. 
For actual usage we used the definition of Straub et al. (1995): ‘Computer-recorded system 
usage, categorized as heavy, moderate, light or nonuse based on distribution of actual usage. 
However, before the actual usage variable could be used in categorization and further 
analysis, a few modifications were needed.       
 For instance, some participants were able to start earlier in the intervention because of 
an earlier date of surgery than other participants. This led to a prolonged use of the e-health 
devices for self-monitoring. Thus, it was necessary to correct for the amount of time during 
which participants engaged in self-monitoring. In SPSS 22.0 an equal ‘fixed’ period was 
created. The reason for looking at the amount of usage per ‘week’ and not per ‘day’, is 
because not every participant used the self-monitoring devices every day. Reporting the usage 
per week made it easier to interpret the data.      
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 After correcting for time, several methods were examined on how to use the frequency 
of the self-monitoring measurements as an reliable ‘actual usage variable’. First, a composite 
score of blood pressure, weight, steps and temperature was calculated. The composite score 
was used to limit the number of analyses by creating one ‘actual usage’ variable. For this 
purpose, an Principal Component Analysis (PCA) was conducted. Unfortunately, the results 
of the PCA were not reliable because the results were strongly influenced by the participants 
who did not record their steps, weight and temperature. The number of participants that did 
not record measurements ranged from six for frequency of recording weight, to ten for 
frequency of recording steps. Participants measured blood pressure most frequently and on a 
regular base (missing value N = 1). Because of the unreliable results of the PCA, blood 
pressure frequencies, adjusted for the time period of measuring per week was chosen to 
represent the ‘actual usage’ variable. Afterwards, blood pressure frequency measurements 
were categorized in light, moderate or high ‘actual usage’ categories. 
Table 1. Descriptives of ‘Actual usage’ (blood pressure measurements per week) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Descriptives   
n  22 
Missing  1 
M 7.78 
Median 5.83 
SD 6.46 
Minimum .57 
Maximum 24.67 
Percentiles 33 % 3.79 
66 % 8.14 
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Two types of categorizing were considered:  
 
a) Categorization based on the distribution of actual use of blood pressure per week (M = 
7.78, SD = 6.46). This categorization was based on the distribution of the data (Straub 
et al., 1995) using the mean score, minus and plus one standard deviation (Table 1). 
All the scores below 1.32 were labeled as ‘light’ (7.78 - 6.46 = 1.32), scoring between 
1.32 and 14.21 was labeled as ‘moderate’ (7.78 + 6.46 = 14.21) and scoring ‘high’ was 
labeled as scoring higher than 14.21 (Figure 3).  
        
 
Figure 3. Categorization based on the distribution of actual use of blood pressure per week. 
Unfortunately there was an unequal distribution of participants, most people scored in the 
moderate category. Only 1 participant scored in the light category, 18 participants scored in 
the moderate category and 3 participants in the high category. It was decided that it would be 
more useful if the group size is approximately equal. Therefore it was decided to categorize 
based on an equal group size per category of blood pressure.  
b) Categorization based on group size (i.e., equally large groups of participants, Figure 4, 
Table 2). The categorization was based on percentile scores (shown in Table 1) and 
used for further analysis in a MANOVA. 
 
Light < 1.32 moderate  < 14.21 high > 14.21 
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Figure 4. Categorization based on group size. 
Table 2. Descriptives of categorization based on group size 
Categories 
 
Frequency of participants 
 
Percent 
 
Light use 
7 31.8 
Moderate use 
8 36.4 
High use 
7 31.8 
Total 22 100 
 
Self-efficacy                                                                                                     
For measuring self-efficacy, the Partners in Healthcare (PiH-scale) was used, adapted to 
ESRD patients (Battersby, Ask, Reece, Markwick & Collins, 2003) and measured at baseline. 
The scale measured the individual’s confidence to carry out behaviour necessary in self-
managing their chronic kidney condition (Bandura, 1997). Furthermore, the scale was based 
on several principles of self-management, for instance: being confident in knowing the 
condition and the treatment options and in engaging in health promoting activities (Battersby 
et al., 2003). The PIH-scale included thirteen items, for instance: ‘I can monitor the symptoms 
of my kidney disease’. The items were rated on a nine-point Likert scale ranging from 1 ‘very 
bad’ to 9 ‘very good’. Higher scores indicated good self-efficacy of self-management and 
lower scores indicated a poor self-efficacy of self-management. Furthermore, the internal 
consistency was found to be high (α = .85). 
33.3% 33.3% 33.3% 
light < 3.80 moderate  < 8.14 high > 8.14 
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Transplant worries               
For measuring transplant worries, the transplant worry-scale of the Transplant Effects 
Questionnaire (TxEQ) was used, which consisted of six items (Ziegelmann et al., 2002).  
Transplant worries could not be measured at baseline, as we could not ask for anxiety to lose 
a graft before surgery; therefore it was measured at follow-up. The scale measured the level of 
worries and concerns regarding the function of the new kidney (Ziegelmann et al., 2002). Five 
items of the TxEQ were used: for instance: ‘I am worried about damaging my transplant’. The 
items were rated on a five-point Likert scale ranging from 1 ‘fully agree’ to 5 ‘fully disagree’. 
Higher scores indicated more transplant worries and lower scores indicated a less transplant 
worries. Furthermore, the internal consistency was found to be high (α = .87). The item: ‘I 
worry each time my anti-rejection drug regime is altered by my doctor’ decreased Cronbach’s 
alpha from α = .87 to α = .16, therefore the item was left out the scale. 
Perceived ease of use               
For measuring perceived ease of use of the Medical Dashboard, a scale that was not validated 
yet was measured at follow-up. Perceived ease of use can be defined as ‘the degree to which 
the person believes that using the particular system would be free of effort’ (Davis, as cited in 
Sharp, 2007). The scale consisted of two items, for instance: ‘Working with the Medical 
Dashboard will cost me little effort’. The items were rated on a five-point Likert scale, 
ranging from 1 ‘fully agree’ to 5,’fully disagree’. Higher scores indicated more perceived ease 
of use and lower scores indicated less perceived ease of use. Moreover, the internal 
consistency was found to be reasonable (α = .61).                          
 
Perceived usefulness                                               
For measuring perceived usefulness of the Medical Dashboard, a scale which was not 
validated yet was measured at follow up. Perceived usefulness can be defined as ‘the degree 
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to which the person believes that using the particular system would enhance his or her job 
performance’ (Davis, as cited in Sharp, 2007). The scale consisted of three items, for instance: 
‘I find working with the MD useful’. The items were rated on a five-point Likert scale, 
ranging from 1 to 5, with a score of 1’ fully agree’ to a score of 5 ’fully disagree’. Higher 
scores indicated more perceived usefulness and lower scores indicated less perceived 
usefulness. Additionally, the internal consistency was found to be high (α = .87). 
Internal Consistency 
The reliability of the scales was analysed by performing a Cronbach’s Alpha reliability test 
(Table 3.). A high internal consistency (α = .85) was found for self-efficacy, transplant 
worries and perceived usefulness. Perceived ease of use showed a reasonable internal 
consistency (α = .61). 
Table 3. Cronbach’s alpha of the scales 
Scale Number of items α 
Self-efficacy                          13            .85 
Transplant worries 5 .87 
Perceived ease of use 2 .61 
Perceived usefulness 3 .87 
 
 
Statistical Analyses 
First, the assumptions of multicollinearity, normality, linearity and homoscedasticity were 
checked. All analysis were conducted in IBM SPSS 22.0 and a significance level of p <.05 
was applied for testing the hypotheses. 
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Multivariate analysis of variance. 
To assess if higher levels of (the independent interval variables) self-efficacy (=H1), worries 
(= H2), perceived usefulness (=H3) and perceived ease of use (= H4) are associated with (the 
independent nominal variable) actual usage, a one-way MANOVA was conducted. In order to 
conduct a MANOVA, the effect of an independent ordinal variable(s) must be compared to 
dependent interval/ratio variable(s). Therefore, self-efficacy, transplant worries, perceived 
ease of use and perceived usefulness were used as dependent interval variables (although 
these variables were formulated as independent interval variables in the hypotheses). Actual 
usage was used as the independent ordinal variable (in the hypotheses described as an 
dependent ordinal variable).  
Correlation analysis. 
To test if higher self-efficacy is associated with more perceived ease of use and (= H5) and if 
higher transplant worries are associated with more perceived usefulness (= H6), two Pearson 
correlation (one-tailed) analyses were conducted.  
RESULTS 
38 participants were approached and eventually 25 participants took part in the pilot (Table 
4). However, two participants were lost to follow-up due to health problems, which makes N 
= 23 in the total sample. In total 5 participants were female (21.7%) and 18 participants were 
male (78.3%). The age varied between 22 and 69 years and the mean age was 45 years (M = 
44.87, SD = 13.15). The majority of the participants were in the possession of a lower 
secondary education diploma (39.1%) or a diploma in higher education (34.8%) and used 
computers (N =19) and the internet (N =20) on a daily base. Furthermore, the participants 
scored above average on the levels of self-reported self-efficacy, transplant worries, perceived 
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ease of use and usefulness (Table 5). The data was examined to confirm no violation of the 
assumptions of univariate and multivariate normality, linearity, outliers and homoscedasticity 
were made, with no serious violations noted.   
Table 4. Patient characteristics  
 
Characteristic 
 
N 
 
(%) 
 
M 
 
SD 
 
Minimum  
 
Maximum 
 
 
Gender 
     Male 
     Female 
 
18 
5 
 
78.3 
21.7 
    
 
Age 
 
23 
 
- 
 
44.87 
 
13.16 
 
22 
 
69 
 
Marital Status 
     Single 
     Married/Living- 
     together 
     Divorced 
     Widow/Widower 
   
 
5 
16 
 
1 
1 
 
 
21.7 
69.6 
 
4.3 
4.3 
    
 
Education 
     Vocational education 
     Lower secondary-  
     education 
     Higher secondary-  
     education 
     Higher education  
 
 
1 
9 
 
5 
 
8 
 
 
4.3 
39.1 
 
21.7 
 
34.8 
    
 
Computer usage 
     Daily 
     Four times per week 
     Two times per week 
 
 
19 
3 
1 
 
 
82.6 
13.0 
4.3 
    
 
Internet Usage 
     Daily 
     Four times per week 
     Weekly 
 
 
20 
2 
1 
 
 
87.0 
8.7 
4.3 
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Table 5. Patients self-reported levels of self-efficacy, transplant worries, perceived 
usefulness and perceived ease of use. 
Variable N Minimum Maximum M SD 
Self-efficacy 23 5.77 9.00 7.75 .81 
Perceived usefulness 23 2.00 5.00 3.78 .66 
Transplant worries 23 1.40 4.60 3.42 .89 
Perceived ease of use  23 1.50 4.50 3.67 .75 
 
Transplant worries, self-efficacy, perceived ease of use and perceived usefulness 
associations to  levels of usage                                  
A one-way between-groups multivariate analysis of variance was conducted to examine if 
higher levels of self-efficacy (= H3), transplant worries (= H4), perceived ease of use (= H5) 
and perceived usefulness (= H6) would be associated to higher actual usage of the MD. Using 
Pillai’s trace, there were no significant differences in the categories of actual usage on the 
combined scores of self-efficacy, transplant-worries, perceived ease of use and perceived 
usefulness scores V = 0.16, F(8, 34) = 0.36, p = .936. This result is not in line with the 
hypotheses and therefore it was concluded that participants with higher levels of self-
efficacy(= H3), transplant worries (= H4), perceived ease of use (= H5) and perceived 
usefulness (= H6) are not positively associated with the higher levels of actual usage of the 
MD. Consequently, no further exploration of the univariate ANOVAs was permitted and 
these hypotheses were rejected. 
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Self-efficacy predicting perceived ease of use 
To examine if participants with higher scores on self-efficacy would perceive the MD easier 
to use (= H5), a Pearson correlation (Table 5) was assessed. No significant correlation r = 
.125, p = > .285 was found. The hypothesis was rejected. 
Transplant worries predicting perceived usefulness 
To examine if patients with higher levels of transplant worries would perceive the MD as 
more useful (= H6), a Pearson correlation (Table 5) was assessed. A positive correlation r = 
.433, p = .019 was found. This is in line with the hypothesis that participants with higher 
levels of transplant worries perceive the MD as more useful. Therefore, the hypothesis was 
accepted. 
 
Table 5. Correlations between  Actual Usage, Self-efficacy, Worries, perceived Usefulness and perceived 
Ease of Use 
 
Actual Usage 
 
 Usefulness 
 
   Worries 
  
  Self-efficacy 
 
Ease of use 
  
Pearson 
Correlation 
 
 
 
 
 
 
Actual Usage                 -     
 
Perceived 
Usefulness 
 
.216              -    
 
Worries  .014    .433*             -   
 
Self-efficacy .160 -.124 -.237              -  
  
Perceived Ease 
of use  
                .013                  .110 -.135 .125 
 
     - 
 
Note. *= statistically significant at p < .05 (1-tailed) level. 
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DISCUSSION 
New eHealth technologies have rapidly evolved in the last few years and provide strategies 
for tracking important health information (Smarr et al., 2011). However, the usage of these 
new eHealth technologies is an area of underexplored research. This study integrated the 
Medical Dashboard (MD), a new eHealth application for self-monitoring, into the regular 
healthcare for transplant renal patients. The extended version of the Technology Acceptance 
Model (TAM) was used as a framework to investigate factors that might be related to usage of 
the MD. The results of this study showed that higher levels of self-efficacy, transplant 
worries, perceived ease of use and perceived usefulness did not result in higher levels of 
actual usage. Additionally, self-efficacy is found not to be associated with the perceived ease 
of use of the MD. However, patients with higher levels of transplant worries did perceive the 
MD as more useful than less worrisome patients.       
 Several explanations exist for the unexpected findings that participants who reported 
higher self-efficacy (= H1), transplant worries ( = H2), ease of use (= H3) and usefulness (= 
H4) levels, did not actually used the MD more frequently than participants with lower scores 
on those predictors. An explanation can be found in the method of measuring actual usage. 
Previous studies typically measured actual usage by self-reports and only a few studies 
included objective actual usage (Donkin et al., 2011; Legris, Ingham & Collerette, 2003). The 
current study measured objective (system-recorded) actual usage, which has advantages over 
self-reports. For objective usage is associated with a lower risk of recall bias (Davis, 1992). A 
recall bias can occur when participants cannot remember an event because of a long period 
between the occurrence and the recall of the event (Biemer, Groves, Lyberg, Mathiowetz & 
Sudman, 1991). Consequently, recalling can result in overestimation or underestimation of the 
occurrence of the event (Berolo, Steenstra, Amick, & Wells 2015; Biemer et al., 1991). 
Therefore the use of an objective measure was a strength of this study.              
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Nevertheless, this study’s use of an objective measure might have contributed to the null-
findings. Prior research also indicated that the predictors of the TAM were considerable less 
associated with objective actual usage than self-reported usage (Straub et al., 1995; Szajna, 
1996; Turner, M., Kitchenham, Brereton, Charters and Budgen, 2010). This raises the 
question why it is harder to establish an objective usage variable in the TAM than self-
reported use, especially when the former is expected to have advantages over self-report. One 
possibility is that the current methods for objective usage measurements might be less valid 
and reliable. In addition, Turner and colleagues (2010) believed that objective usage 
measurements might be more difficult to measure because of the requirements of complex 
computer-recorded methods. As a result, objective usage is studied less extensive than self-
report usage studies (Turner et al., 2010).       
 Additionally,  there is a lot of variation in the way previous research measured actual 
usage, for example including the number of loggings (Dybâ, Moe & Arisholm, 2005), actual 
usage date from log files  (Dasgupta, Granger & McGarry, 2002), generic information of 
participants application usage (Berolo et al., 2015), or they did not specifically explain their 
method. In the current study actual usage was measured by using the frequency of blood 
pressure uploads. Initially, we wanted to measure actual usage with a composit variable that 
could also take into account the number of steps, weight measurements and temperature 
measurements. Yet, these measurements could not be integrated in the objective usage 
variable, as many participants did not record their steps, weight and temperature. Future 
studies should be aimed at developing methods to measure objective actual usage in a valid, 
reliable and feasible manner. For example, comparing various methods of computer-recorded 
use to determine which method is optimal to represent objective usage.    
 An alternative explanation might be that other factors influence actual usage. In 
previous research, the TAM model is widely used to predict behavioral intention, which is 
32 
 
 
The Medical Dashboard 
 
suggested to determine one’s actual behaviour towards using and accepting new technologies 
(Ajzen & Fishbein, as cited in Davis, 1986). However this link between behavioral intention 
and actual usage behaviour is not extensively investigated in previous research (Pynoo & 
Braak, 2014), nor in this study. Earlier research refer to this weak link as the ‘intention –
behaviour gap’ that refers to the unclear (underlying) process that bridges the discrepancy 
between intention to act and subsequent actual behavior (Bhattacherjee & Sanford, 2009; 
Sniehotta, Scholz & Schwarzer, 2005). Additionally, the associations between intention and 
actual usage were mainly found in lab-settings and for self-reported usage (Yousafzai, Foxall 
& Pallister, 2007). As a result, it is unknown to which extend behavioral intention influences 
actual usage and if other factors might explain why we did not find an effect on usage. 
Nevertheless, behavioral intention is a key aspect of the TAM and future TAM research in 
health care settings should further investigate the influence of intention (or other factors) on 
actual usage.          
 Currently, the TAM model might not be adequate in predicting the use of eHealth 
applications such as the MD, in the complex organizational environment of health care. 
Recent research suggested that the adoption of new (e.g. health) technologies in 
multidisciplinary organizational systems is difficult, because of the diverse technologies used 
in various groups and inter-related social, technological and organizational factors that might 
influence the implementation (Cresswell & Sheikh, 2013; Cresswell, Worth & Sheikh, 2010; 
Legris, Ingham and Collerette, 2003). Legris and colleagues (2003) suggested to extend the 
TAM  with organizational and social factors to improve the predictive ability of the TAM. For 
instance support of professionals or support of the organizational environment (Cresswell & 
Sheikh, 2013). Additionally, a recent longitudinal study found that personal feedback during 
the use of an web-based monitoring application was best in engaging diabetes patients 
(Nijland, Gemert-Pijnen, Kelders, Brandenburg & Seydel, 2011). Despite the fact that the 
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nephrologists were instructed to show and discuss the Medical Dashboard with their patients 
during the consults, most of the time this was not the case. This is unfortunate since personal 
and interactive feedback can increase patients feelings of being adequately monitored, thus it 
can motivate them and the staff to be actively participated in self-management and health care 
and (Nijland et al., 2011).                   
 Besides that no effects of the predictors of the TAM on actual usage were found, also 
no relationship between self-efficacy and ease of use (= H5) is found. This means that 
participants who had more confidence in self-managing their chronic kidney disease did not 
report that the MD was more easy to use. A possible explanation is that self-efficacy was 
assessed with a generic self-report questionnaire. The questionnaire was mainly directed at 
patients’ confidence in handling their chronic disease. The  self-efficacy questions were not 
targeted at, for instance, their confidence in handling computers or an eHealth technology for 
self-monitoring their health.         
 A potential solution would be to adopt a more eHealth application specific self-
efficacy definition or operationalization, for instance general computer self-efficacy (CSE), or 
application specific CSE. General CSE refers to someone’s confidence in their own ability in 
using computers and computer related tasks (Compeau & Higgins, 1995). Specific CSE is the 
person’s belief in own competence in the usage of a specific system or application (Marakas, 
Yi & Johnson, 1998). Several studies found significant effects of general CSE and specific 
CSE on ease of use and actual usage (Hasan, 2006; Marakas, Yi & Johnson, 1998; Mun, Yi & 
Whang, 2003). However, Wangpipatwong, Chutimaskul and Papasratorn (2008) found no 
effect of general CSE on the perceived ease of use of e-Government websites. 
Wangpipatwong and colleagues (2008) assumed that even general CSE may be too general, 
and that a more specific operationalization of self-efficacy regarding the use of the e-
Government website should be considered. In line with this, Marakas, Yi and Johnson (1998) 
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did find that specific CSE had a larger effect on ease of use than general CSE.  
 Therefore future eHealth research, should consider the development an eHealth 
specific CSE. A specific CSE adjusted for the MD should be directed at the participants 
confidence in using apps for self-monitoring and their understanding of the self-care module 
on the internet. On the other hand, the construct of eHealth specific CSE might overlap 
considerably with perceived ease of use, which questions the relevance of developing such a 
specific CSE. By all means, the results of the current and previous research seem to indicate 
that patients’ general self-efficacy with regard to self-management, does not imply that 
patients feel themselves able to use an eHealth application such as the MD with ease.  
 A final explanation why no relation between SE and perceived ease of use is revealed, 
might be due to a ceiling effect. Within the included sample, patients generally scored high on 
SE and were also familiar in using computers, suggesting that the participants probably had 
proficient computer skills beforehand. Computer skills may be considered as a specific CSE 
that is relevant for using the MD. The very high scores and the low level of variance of SE 
and computer skills might be an explanation for the lack of effect of self-efficacy on ease of 
use. Future studies should also include patients with lower levels of SE and computer skills.  
 In our last hypothesis, we argued that transplant recipients with increased levels of 
transplant worries would benefit more from a new self-monitoring eHealth application and 
therefore would perceive the MD as more useful compared to less worrisome transplant 
recipients (= H6). Our results showed that patients with higher levels of transplant worries 
indeed perceive the MD as more useful. Worrisome patients might experience the MD useful, 
because it helps them to lower or control their transplant worries, as previous research has 
found that self-monitoring has positive effects on feelings of confidence in taking control of 
own care (Jones et al., 2012) and can increase one’s feelings of security and reassurance 
(Jaana, Pare & Sicotte, 2012).                   
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Nevertheless, based on the current correlation results, conclusions about causality cannot be 
drawn and therefore a reversed effect cannot be ruled out. Additionally, it was not possible to 
measure transplant worries at baseline, as we could not ask for anxiety to lose a graft before 
surgery; therefore transplant worries was measured at follow-up. Hence, it is not clear if 
participants who scored high on worries, also experienced high transplant worries at baseline. 
Therefore, patients that initially perceived the MD as more useful might get more worried 
about their transplant later on. This could be explained by the following reasoning: patients 
that perceived the MD as useful might initially have been involved in more frequent and up 
close self-monitoring, which eventually induced more transplant worries. In fact, most 
patients who refused to participate in the current study, reported that they were concerned that 
closely self-monitoring would confront them (too much) with their poor health status and 
therefore self-monitoring could induce extra worrying. In line with this reasoning, some 
patients might have avoided using the MD on the longer term, because they are were afraid of 
increased transplant worries, which also could be a reason why no link was found with actual 
usage.  Future eHealth research initiatives should rule out which causal directions in the 
relationship between transplant related worrying, self-monitoring and perceived usefulness of 
eHealth applications are most likely.        
 This study has some limitations. Besides limitations already mentioned, another 
important limitation is related to the use of the MD. Participants had to keep track of the two 
separate apps as well as the website, which might have been not feasible for them. It might 
have caused confusion or it took patient too much time, which could explain why patients did 
not record their steps, weight and temperature. Future eHealth research should consider 
developing an integrated application to prevent participants from having to go back and forth 
between logging into their mobile phone and their computer. Additionally, it is noteworthy 
that the sample size was small and therefore a larger margin of error is possible (Saunders, 
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Lewis, Thornhill, Booij & Verckens, 2011), in turn this may have played a role in the null-
findings. Moreover, although perceived ease of use and perceived usefulness scores were 
quite high, some participants reported that the design of the application was somewhat 
redundant. A clearer eHealth application might positively affect perceived ease of use and 
perceives usefulness and could encourage and motivate participants in using the application. 
Finally, it was not possible to measure transplant worries at baseline, what makes it 
questionable if transplant worries has changed over time or not.      
 Despite these limitations, various strengths can be observed. To our knowledge, this is 
the first study incorporating transplant worries into TAM research, which led to the finding 
that worrisome patients might benefit most of a self-monitoring eHealth application. Another 
strength is the implementation of the intervention in a natural setting (e.g. the hospital and at 
home), because many TAM-studies have been performed with students (Legris, Ingham & 
Collerette, 2003). As a result, the experiences with the MD of the patients and hospital’s 
stakeholders gave us insight in their needs and future directions for improvement. Finally, we 
attempted to integrate objective actual usage data in executing this study. Although further 
work is required to gain a better understanding of including objective actual usage data, this 
study distinguishes itself from other studies who typically use self-report data.  
CONCLUSION 
In this study, the relationships between renal transplant recipients’ self-efficacy, perceived 
ease of use, perceived usefulness, self-efficacy, transplant worries and actual usage of the 
MD, a new eHealth application, were investigated by means of an extended version of the 
TAM. No effect of the predictors were found on actual usage nor an effect of self-efficacy on 
ease of use. Nevertheless, a positive relationship between transplant worries and perceived 
usefulness was found. For clinical practise the current results cautiously imply, that 
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worrisome patients might benefit most of the MD eHealth application. This emphasizes a 
possible positive effect of the MD on the patients confidence and support in regulating one’s 
own care (Jaana, Pare & Sicotte, 2012; Jones et al., 2012), which is suggested to lower 
transplant worries. Thus, future interventions in health-care might consider improving 
patient’s perceived usefulness of eHealth applications in order to stimulate positive effects on 
patient disease-related worrying. However this advice should be taken with caution, since we 
cannot conclude about causality and therefore we cannot rule out an reversed effect.  
 Moreover, in the current study the TAM was not yet able to predict actual usage of the 
MD eHealth technology. Future eHealth studies could improve the predictive ability of the 
TAM by including a larger sample size and sufficiently tailor the model to the health-care 
setting. For instance, incorporate social and organizational factors such as professional 
support or personal feedback. Moreover these initiatives should ensure that agreements with 
doctors about giving for instance feedback, are kept, since this was not always the case in the 
current study. Future eHealth research directions are: 1) investigating to what extend a new 
eHealth application reliefs and supports (transplant or other disease-related) worries, or 
whether it actually induces worries; 2) Adapt the TAM model to healthcare; 3) Investigate the 
link between behavioural intention and actual usage behaviour; 4) Develop an eHealth 
application specific self-efficacy measure and investigate the added value of such a measure; 
5) Developing methods to measure actual eHealth application usage in a valid, reliable and 
feasible manner. 
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Appendix 1 
 
The Medical Dashboard 
 
  
Adapted from: Paul vd. Boog, (2014). 
Meting Datum Waarde Persoonlijk Algemeen
Biometrisch
Z Bloeddruk ZH (mmHg) 4-1-2013 145/85 < 140/85 < 140/90
T Bloeddruk Thuis (mmHg) 4-1-2013 130/78 < 130/80 < 130/80
T Gewicht (kg) 4-1-2013 81,5 < 82 < 85
Laboratorium
Z Kreatinine 4-1-2013 125 130
Z Cholesterol (LDL) (mmol/l) 4-1-2013 4,2 < 3,0 <  2,6
Z HbA1c 4-1-2013 40 < 42 < 42
24 uurs urine
Z Natrium (mmol/24 uur) 4-1-2013 210 150 100
Z Eiwit (gram/24 uur) 4-1-2013 0,5 0,6 <  0,18
Beweging
T Aantal stappen/dag 20-12-2012 6000 5600 10.000
Richtlijn
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Appendix 2 
 
Baseline questionnaire  
 
 
 
LUMC Medical Dashboard 
Vragenlijst gebruikersonderzoek 
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Geachte Mevrouw/Mijnheer, 
 
Voor u ligt een vragenlijst. Eerst stellen we een paar algemene vragen. Daarna volgen een 
aantal vragen over uw verwachtingen over het Medical Dashboard en over uw ervaringen met 
het hebben van een nierziekte. Het invullen van de vragenlijst kost u ongeveer 10 minuten. 
 
De antwoorden zijn niet goed of fout, maar hebben betrekking op uzelf. Het gaat erom dat u 
de vragen zo eerlijk mogelijk beantwoordt en uw eigen mening geeft. Het is niet de bedoeling 
dat u erg lang gaat nadenken over de antwoorden.  
 
Bij de meeste vragen staan een aantal antwoordmogelijkheden aangegeven. U kunt het 
antwoord dat voor u het meest van toepassing is aankruisen. Het kan voorkomen dat u een 
'verkeerd' hokje aankruist en dat u dit wil veranderen. Geef dit aan door het 'verkeerde' hokje 
helemaal zwart te maken. Kruis daarna het juiste antwoord aan. Wilt u altijd bij alle vragen 
één antwoord aankruisen? 
 
 
 
Mocht u vragen hebben over het invullen van de vragenlijst dan kunt u contact opnemen met 
een onderzoeker van het Leids Universitair Medical Centrum, mevrouw Sandra van Dijk, op 
telefoonnummer 071-5273913, of via email: S.van_Dijk@lumc.nl. 
 
Wanneer de hele vragenlijst is ingevuld, kunt u de vragenlijst inleveren bij Vera Zonderop. 
De antwoorden op de vragenlijsten zijn alleen ter inzage voor de onderzoekers en zullen 
anoniem behandeld worden aan de hand van de persoonlijke code die op de vragenlijst staat.  
 
Bij voorbaat hartelijk dank voor het invullen van de vragenlijst! 
 
 
49 
 
 
The Medical Dashboard 
 
 
 
 
Hieronder volgen enkele algemene vragen over uzelf. Wilt u bij elke vraag een kruisje zetten 
in het hokje dat het beste bij u past. 
 
1. Wat is uw geboortedatum? ……-………-…….. (dag/maand/jaar) 
 
2. Bent u…. 
  Alleenstaand 
  Getrouwd / samenwonend met partner 
  Gescheiden (niet samenwonend) 
  Weduwe / weduwnaar 
  Anders, namelijk ……………………… 
 
3.   Heeft u kinderen?  
  Ja, hoeveel? ………………. 
  Nee 
 
4.   Wat is de hoogste (school)opleiding die u heeft afgemaakt? 
  Lager onderwijs (basisschool)   
  Beroepsonderwijs 
  Middelbaar voortgezet onderwijs  
  Hoger voortgezet onderwijs  
  Hoger (beroeps-)onderwijs 
 
5.   Werkt u op dit ogenblik? 
  Nee 
  Ja, deeltijd (........uur per week) 
  Ja, voltijd 
Algemene vragen 
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6.   Hoe vaak per week zit u achter de computer?  
  Dagelijks 
  Vier keer per week 
  Twee keer per week 
  Wekelijks 
  Een keer in de twee weken 
  Maandelijks 
  Nooit 
 
7. Hoe vaak per week zit u op internet?  
  Dagelijks 
  Vier keer per week 
  Twee keer per week 
  Wekelijks 
  Een keer in de twee weken 
  Maandelijks 
  Nooit 
 
8. Heeft u een e-mailadres?  
  Ja 
  Nee 
 
 
Omgaan met een nierziekte betekent dat u zelf maatregelen neemt om zo goed mogelijk met 
uw nierziekte om te gaan. De volgende uitspraken zijn bedoeld om na te gaan in welke mate u 
denkt dat u in staat bent om zulk soort maatregelen te nemen of dingen te doen. Kruis het 
hokje aan dat het beste overeenkomt met uw inschatting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 
Omgaan met uw nierziekte 
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Heel 
slecht    
Vol-
doende   
Heel 
goed 
1. Ik weet en begrijp wat mijn 
nierziekte inhoudt 
         
2. Ik weet welke 
mogelijkheden er zijn om 
mijn nierziekte te 
behandelen 
         
3. Ik kan meebeslissen over de 
behandeling van mijn 
nierziekte 
         
4. Ik regel de (vervolg) 
afspraken die mijn arts heeft 
voorgesteld en kom die ook 
na 
         
5. Ik gebruik mijn medicijnen 
zoals mijn arts heeft 
voorgeschreven 
         
6. Ik begrijp waarom ik de 
verschijnselen van mijn 
nierziekte moet bijhouden 
en noteren 
         
7. Ik kan de verschijnselen van 
mijn nierziekte bijhouden en 
noteren 
         
8. Ik weet wat ik moet doen als 
de verschijnselen van mijn 
nierziekte erger worden 
         
9. Ik kan zelf ingrijpen als de 
verschijnselen van mijn 
nierziekte erger worden 
         
10. Ik kan met de fysieke 
gevolgen van mijn 
nierziekte omgaan 
         
11. Ik kan met de sociale 
gevolgen van mijn 
nierziekte omgaan 
         
12. Ik kan met de emotionele 
gevolgen van mijn 
         
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Geheel 
oneens Oneens 
Enigs-
zins 
oneens 
Noch 
eens, 
noch 
oneens 
Enigs-
zins 
eens Eens 
Geheel 
eens 
1. Ik kan zelfstandig 
beslissingen nemen over 
wat het beste is voor mijn 
gezondheid 
       
2. Ik vind het belangrijk dat 
mijn arts mij betrekt bij 
mijn behandeling 
       
3. Ik vind het prettig als mijn 
arts bepaalt wat het beste 
voor mij is 
       
4. Ik durf binnen mijn 
behandeling zelf keuzes te 
maken 
       
 
Veel mensen met een nieraandoening bezoeken regelmatig een nefroloog in het ziekenhuis. 
De onderstaande uitspraken gaan over de manier waarop u zich ondersteund voelt door uw 
nefroloog. Wilt u aankruisen in hoeverre u het oneens of eens bent met deze stellingen?  
 
 
 
Geheel 
oneens Oneens 
Enigs-
zins 
oneens 
Noch 
eens, 
noch 
oneens 
Enigs-
zins 
eens Eens 
Geheel 
eens 
1. Mijn nefroloog laat mij 
voldoende keuze bij 
beslissingen 
       
2. Ik voel me begrepen door 
mijn nefroloog 
       
3. Mijn nefroloog heeft er 
vertrouwen in dat ik 
       
nierziekte omgaan 
13. Het lukt mij om steeds 
gezonder te gaan leven 
         
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dingen in mijn leven kan 
veranderen 
4. Mijn nefroloog moedigt 
me aan vragen te stellen 
       
5. Mijn nefroloog luistert 
naar hoe ik de dingen zou 
willen aanpakken 
       
6. Ik kan mijn gevoelens 
delen met mijn nefroloog  
       
7. Mijn nefroloog stelt vast in 
welke mate ik betrokken 
wil worden bij 
beslissingen.  
       
8. Mijn nefroloog gaat na 
welke zorgen (angsten) ik 
heb over  
de aanpak van problemen. 
       
 
 
U doet mee aan een gebruikersonderzoek op de afdeling Nierziekten. Hoewel u nog geen of 
nauwelijks ervaring heeft met het Medical Dashboard willen we graag weten wat uw 
verwachtingen zijn over het Medical Dashboard. 
 
 
 
 
Helemaal 
mee eens 
 
 
Mee 
eens 
Niet 
eens/ 
niet 
oneens 
 
 
Mee 
oneens 
 
Helemaal 
mee 
oneens 
1.  Meedoen met het Medical Dashboard 
gebruikersonderzoek zal mij duidelijk inzicht 
geven in mijn gezondheid 
     
2. Door mee te doen met het Medical Dashboard 
gebruikersonderzoek zal ik mijn gezondheid 
kunnen verbeteren. 
     
3. Door mee te doen met het Medical Dashboard 
gebruikersonderzoek zal ik beter op mijn 
gezondheid kunnen letten. 
     
4. Met behulp van het Medical Dashboard zal ik 
een grotere rol kunnen spelen binnen de zorg 
     
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voor mijn eigen gezondheid. 
5. Werken met het Medical Dashboard zal me 
weinig moeite kosten. 
     
6. Een nadeel van meedoen met het Medical 
Dashboard gebruikersonderzoek vind ik dat ik 
veel tijd kwijt zal zijn aan het uitvoeren en 
invullen van zelfmetingen. 
     
7. Werken met het Medical Dashboard zal ik 
interessant vinden. 
     
8. Werken met het Medical Dashboard zal ik als 
iets vervelends ervaren. 
     
9. Werken met het Medical Dashboard zal ik 
prettig vinden. 
     
10. Werken met het Medical Dashboard zal me een 
onrustig gevoel geven. 
     
11. Werken met het Medical Dashboard zal ik 
nuttig vinden. 
     
12. Werken met het Medical Dashboard zal het 
contact met mijn dokter kunnen verbeteren. 
     
13. Door het werken met het Medical Dashboard 
zal ik me geruster kunnen voelen over de 
werking van mijn nieuwe nier. 
     
14. Door het Medical Dashboard zal ik een beter 
gevoel van controle krijgen over mijn 
nierziekte. 
     
15. Door het Medical Dashboard zal ik beter 
vragen kunnen stellen aan mijn nefroloog. 
     
16. Door het Medical Dashboard zal ik beter 
doelen voor mijn gezondheid kunnen stellen. 
     
Bij het gebruikersonderzoek wordt u ook gevraagd om metingen bij te houden. We willen u 
graag een paar vragen stellen over bewegen. 
 
Bewegen 
1. Hoe vaak heeft u de afgelopen twee weken aan recreatieve fysieke activiteiten of sporten 
gedaan gedurende tenminste 30 minuten (bijvoorbeeld wandelen of fietsen) en zo ja, 
hoeveel gemiddeld?  
 Nooit 
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 .......keer per week gedurende .........minuten per keer 
 
2. Heeft u van uw nefroloog wel eens het advies gekregen om meer lichaamsbeweging te 
nemen? 
 Ja 
 Nee 
 
3. In hoeverre zijn de volgende uitspraken op u van toepassing? 
 
  
Helemaal 
mee eens 
Mee 
eens 
Niet 
eens/niet 
oneens 
Mee 
oneens 
Helemaal 
mee 
oneens 
a. Ik zou graag meer willen bewegen      
b. Ik heb er vertrouwen in dat ik meer kan 
bewegen als ik het probeer 
     
 
Dit is het einde van de vragenlijst. 
 
Heeft u misschien nog opmerkingen? 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
 
Hartelijk dank voor het invullen! 
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Appendix 3 
Follow-up questionnaire  
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Geachte Mevrouw/Mijnheer, 
 
Voor u ligt een vragenlijst. Eerst stellen we een paar algemene vragen. Daarna volgen een 
aantal vragen over uw verwachtingen over het Medical Dashboard en over uw ervaringen met 
het hebben van een nierziekte. Het invullen van de vragenlijst kost u ongeveer 10 minuten. 
 
De antwoorden zijn niet goed of fout, maar hebben betrekking op uzelf. Het gaat erom dat u 
de vragen zo eerlijk mogelijk beantwoordt en uw eigen mening geeft. Het is niet de bedoeling 
dat u erg lang gaat nadenken over de antwoorden. 
 
Bij de meeste vragen staan een aantal antwoordmogelijkheden aangegeven. U kunt het 
antwoord dat voor u het meest van toepassing is aankruisen. Het kan voorkomen dat u een 
'verkeerd' hokje aankruist en dat u dit wil veranderen. Geef dit aan door het 'verkeerde' hokje 
helemaal zwart te maken. Kruis daarna het juiste antwoord aan. Wilt u altijd bij alle vragen 
één antwoord aankruisen? 
 
 
 
Mocht u vragen hebben over het invullen van de vragenlijst dan kunt u contact opnemen met 
een onderzoeker van het Leids Universitair Medisch Centrum, mevrouw Sandra van Dijk, op 
telefoonnummer 071-5273913, of via email: S.van_Dijk@lumc.nl. 
 
Wanneer de hele vragenlijst is ingevuld, kunt u de vragenlijst in bijgaande antwoordenvelop 
opsturen (een postzegel is niet nodig). De antwoorden op de vragenlijsten zijn alleen ter 
inzage voor de onderzoekers en zullen anoniem behandeld worden aan de hand van de 
persoonlijke code die op de vragenlijst staat. Wilt u de vragenlijst binnen 1 week na ontvangst 
invullen en opsturen?  
 
Bij voorbaat hartelijk dank voor het invullen van de vragenlijst! 
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De onderstaande uitspraken gaan over de manier waarop u zich ondersteund voelt door uw 
nefroloog. Wilt u aankruisen in hoeverre u het oneens of eens bent met deze stellingen?  
 
 
 
Geheel 
oneens Oneens 
Enigs-
zins 
oneens 
Noch 
eens, 
noch 
oneens 
Enigs-
zins 
eens Eens 
Geheel 
eens 
1. Mijn nefroloog laat mij 
voldoende keuze bij 
beslissingen 
       
2. Ik voel me begrepen door 
mijn nefroloog 
       
3. Mijn nefroloog heeft er 
vertrouwen in dat ik 
dingen in mijn leven kan 
veranderen 
       
4. Mijn nefroloog moedigt 
me aan vragen te stellen 
       
5. Mijn nefroloog luistert 
naar hoe ik de dingen zou 
willen aanpakken 
       
6. Ik kan mijn gevoelens 
delen met mijn nefroloog  
       
7. Mijn nefroloog stelt vast in 
welke mate ik betrokken 
wil worden bij 
beslissingen.  
       
8. Mijn nefroloog gaat na 
welke zorgen (angsten) ik 
heb over de aanpak van 
problemen. 
       
 
 
 
Steun van uw nefroloog 
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U heeft een donornier gekregen. Mensen die een nieuwe nier krijgen verschillen in de mate 
waarin ze zich wel of geen zorgen maken over hun nieuwe nier. Wilt u aankruisen in hoeverre 
u het oneens of eens bent met de onderstaande stellingen? 
 
 
 
 
 
Helemaal 
mee eens 
 
 
Mee 
eens 
Niet 
eens/ 
niet 
oneens 
 
 
Mee 
oneens 
 
Helemaal 
mee 
oneens 
1.  Wat betreft mijn donornier heb ik het gevoel 
iets kwetsbaars bij me te dragen 
     
2. Ik aarzel om bepaalde activiteiten te 
ondernemen omdat ik bang ben schade toe te 
brengen aan mijn donornier 
     
 
 
 
 
Helemaal 
mee eens 
 
 
Mee 
eens 
Niet 
eens/ 
niet 
oneens 
 
 
Mee 
oneens 
 
Helemaal 
mee 
oneens 
3. Ik maak me er zorgen over dat mijn donornier 
beschadigd raakt. 
     
4. Ik houd mijn lichaam beter in de gaten dan 
voor de transplantatie 
     
5. Ik maak me iedere keer weer zorgen als mijn 
arts het schema voor het innemen van mijn 
medicijnen tegen afstoting wijzigt 
     
6. Ik blijf me afvragen hoe lang mijn donornier 
blijft functioneren 
     
 
 
 
Meedoen aan het gebruikersonderzoek 
 
Uw transplantatie 
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Bij het gebruikersonderzoek werd u gevraagd om metingen bij te houden. We willen u graag 
een paar vragen stellen over bewegen. 
 
Bewegen 
4. Hoe vaak heeft u de afgelopen twee weken aan recreatieve fysieke activiteiten of sporten 
gedaan gedurende tenminste 30 minuten (bijvoorbeeld wandelen of fietsen) en zo ja, 
hoeveel gemiddeld?  
 Nooit 
 .......keer per week gedurende .........minuten per keer 
 
 
5. Heeft u van uw nefroloog in de afgelopen periode het advies gekregen om meer 
lichaamsbeweging te nemen? 
 Ja 
 Nee 
 
6. In hoeverre zijn de volgende uitspraken op u van toepassing? 
 
  
Helemaal 
mee eens 
Mee 
eens 
Niet 
eens/niet 
oneens 
Mee 
oneens 
Helemaal 
mee 
oneens 
a. Ik zou graag meer willen bewegen      
b. Ik heb er vertrouwen in dat ik meer kan 
bewegen als ik het probeer 
     
 
 
 
We willen graag weten wat uw ervaringen zijn met het Medical Dashboard. In hoeverre bent 
u het eens met de onderstaande uitspraken? 
 
 
 
 
Helemaal 
mee eens 
 
 
Mee 
eens 
Niet 
eens/ 
niet 
oneens 
 
 
Mee 
oneens 
 
Helemaal 
mee 
oneens 
1.  Meedoen met het Medical Dashboard 
gebruikersonderzoek heeft mij duidelijk inzicht 
     
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gegeven in mijn gezondheid 
2. Door mee te doen met het Medical Dashboard 
gebruikersonderzoek heb ik mijn gezondheid 
kunnen verbeteren. 
     
3. Door mee te doen met het Medical Dashboard 
gebruikersonderzoek heb ik beter op mijn 
gezondheid kunnen letten. 
     
4. Met behulp van het Medical Dashboard heb ik 
een grotere rol kunnen spelen binnen de zorg 
voor mijn eigen gezondheid. 
     
5. Werken met het Medical Dashboard heeft me 
weinig moeite gekost. 
     
6. Een nadeel van meedoen met het Medical 
Dashboard gebruikersonderzoek vond ik dat ik 
veel tijd kwijt was aan het uitvoeren en 
invullen van zelfmetingen. 
     
7. Werken met het Medical Dashboard vond ik 
interessant. 
     
8. Werken met het Medical Dashboard heb ik als 
iets vervelends ervaren. 
     
9. Werken met het Medical Dashboard vond ik 
prettig. 
     
10. Werken met het Medical Dashboard gaf me 
een onrustig gevoel. 
     
11. Werken met het Medical Dashboard vond ik 
nuttig. 
     
12. Werken met het Medical Dashboard heeft het 
contact met mijn dokter kunnen verbeteren. 
     
13. Door het werken met het Medical Dashboard 
heb ik me geruster gevoeld over de werking 
van mijn nieuwe nier. 
     
14. Door het Medical Dashboard heb ik een beter 
gevoel van controle gekregen over mijn 
nierziekte. 
     
15. Door het Medical Dashboard heb ik beter 
vragen kunnen stellen aan mijn nefroloog. 
     
16. 
Door het Medical Dashboard heb ik beter 
     
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doelen voor mijn gezondheid kunnen stellen. 
 
 
 
 
 
 
 
 
Helemaal 
mee eens 
 
 
Mee 
eens 
Niet 
eens/ 
niet 
oneens 
 
 
Mee 
oneens 
 
Helemaal 
mee 
oneens 
17.  De meeste patiënten zullen het Medical 
Dashboard graag willen gebruiken. 
     
18.  De meeste nefrologen zullen het Medical 
Dashboard graag willen gebruiken. 
     
19. Het Medical Dashboard biedt goede 
ondersteuning om doelen te stellen. 
     
20. Het Medical Dashboard biedt goede 
ondersteuning om nieuwe gedragingen op de 
langere termijn vol te kunnen houden. 
     
21. Het Medical Dashboard sluit goed aan bij de 
problemen die patienten ervaren. 
     
22. Het Medical Dashboard heeft de consulten met 
de nefroloog veranderd. 
     
23. Het Medical Dashboard sluit goed aan op de 
zorg die ik krijg. 
     
24. Het Medical Dashboard zorgde ervoor dat ik 
actiever bij mijn behandeling betrokken ben 
geraakt. 
     
 
Wat is uw oordeel over het Medical Dashboard als geheel? Geef een rapportcijfer van 1-10 
            
Heel 
slecht 
          
Heel 
goed 
 1 2 3 4 5 6 7 8 9 10  
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Wat vindt u goed aan het Medical Dashboard? U kunt meerdere punten noemen. 
 
 
 
 
Wat vindt u (nog) niet goed aan het Medical Dashboard? U kunt meerdere punten noemen. 
 
 
 
 
 
 
 
Dit is het einde van de vragenlijst. 
 
Heeft u misschien nog opmerkingen?  
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
 
Hartelijk dank voor het invullen! 
 
